EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan

Takaaki Yoshimura, Yasuhiro Morii, Honoka Tamori, Ryuki Kita, Takayuki Hashimoto, Hidefumi Aoyama, Katsuhiko Ogasawara

Journal of Radiation Research · 2025

DOI: 10.1093/jrr/rrae086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2025. Verfasst von Takaaki Yoshimura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Faculty of Health Sciences, Hokkaido University, N12-W5, Kitaku, Sapporo 060-0812, Japan. Hauptthemen laut MEDLINE: Proton Therapy, Cost-Benefit Analysis, Medulloblastoma, Cerebellar Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medulloblastomas are one of the most common malignant cancers of the central nervous system in children. Proton beam therapy (PBT) is expected to provide equivalent tumor control to photon therapy while reducing the various adverse events caused by irradiation. Few studies have considered the cost-effectiveness of PBT for pediatric medulloblastoma, considering the multiple adverse effects and reflecting on the latest treatment advancements. A cost-utility analysis of PBT for pediatric medulloblastoma was conducted in a Japanese setting and compared to conventional photon therapy. The analysis was conducted from the public healthcare payer’s perspective, and direct costs for the treatment of radiation therapy and radiation-induced adverse events were included. A Markov model was used, and the health states of secondary cancer, hypothyroidism and hearing loss were defined as adverse events. The time horizon was the lifetime. Incremental cost-effectiveness ratio (ICER) was used as a measurement of cost-effectiveness, with quality-adjusted life years (QALYs) used as an outcome. The costs were estimated from the national fee schedule, and the utility and transition probabilities were estimated from published literature. PBT incurred an additional 1387116 Japanese yen (JPY) and 1.56 QALYs to the comparator. The ICER was JPY 887053/QALY, indicating that PBT was cost-effective, based on the reference value of JPY 5 million/QALY used in the Japanese cost-effectiveness analysis. Deterministic sensitivity analysis showed that the ICER ranged from JPY 284782/QALY to JPY 1918603/QALY as a result of deterministic sensitivity analysis, and probabilistic sensitivity analysis showed that PBT was cost-effective, with a probability of 91.7%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyCost-Benefit AnalysisMedulloblastomaCerebellar NeoplasmsHumansJapanChildQuality-Adjusted Life YearsMarkov ChainsMaleChild, PreschoolFemaleAdolescentCost-Effectiveness Analysis

Stichwörter der Autor:innen

adverse eventscost-effectivenessmedulloblastomaproton beam therapy

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Faculty of Health Sciences, Hokkaido University, N12-W5, Kitaku, Sapporo 060-0812, Japan.
  • Department of Medical Physics, Hokkaido University Hospital, N14-W5, Kitaku, Sapporo 060-8648, Japan.
  • Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, N15-W7, Kitaku, Sapporo 060-8638, Japan.
  • Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, 2-3-6 Minami, Wako 351-0197, Japan.
  • Graduate School of Health Sciences, Hokkaido University, N12-W5, Kitaku, Sapporo 060-0812, Japan.
  • Department of Radiation Oncology, Faculty of Medicine, Hokkaido University, N15-W7, Kitaku, Sapporo 060-868, Japan.

Zitieren

APA

Yoshimura, T., Morii, Y., Tamori, H., Kita, R., Hashimoto, T., Aoyama, H., & Ogasawara, K. (2025). Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrae086

Vancouver

Yoshimura T, Morii Y, Tamori H, Kita R, Hashimoto T, Aoyama H, et al. Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan. Journal of Radiation Research. 2025. doi:10.1093/jrr/rrae086

BibTeX
@article{Yoshimura2025,
  author = {Yoshimura, Takaaki and Morii, Yasuhiro and Tamori, Honoka and Kita, Ryuki and Hashimoto, Takayuki and Aoyama, Hidefumi and Ogasawara, Katsuhiko},
  title = {Cost-effectiveness analysis for multi adverse events of proton beam therapy for pediatric medulloblastoma in Japan},
  journal = {Journal of Radiation Research},
  year = {2025},
  doi = {10.1093/jrr/rrae086}
}
Kostenlos starten →